The Latest Analyst Ratings for Repligen
Portfolio Pulse from Benzinga Insights
Repligen (NASDAQ:RGEN) has received 7 analyst ratings in the last quarter, with 2 bullish and 5 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target among these analysts is $186.71, with a high of $210.00 and a low of $165.00. This target is down 11.68% from the previous average of $211.40. Analysts rate stocks based on research and insights, but their advice may be subject to error.
December 04, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repligen has a positive outlook from analysts with 7 recent ratings being bullish or somewhat bullish. The average price target has decreased by 11.68% to $186.71.
The positive analyst ratings suggest confidence in Repligen's future performance, which could lead to increased investor interest and a potential rise in stock price. However, the decrease in the average price target may temper expectations slightly, hence the importance is not at the maximum. The confidence level is high due to the clear consensus among analysts but not absolute due to the inherent uncertainty in analyst predictions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100